Untargeted Metabolomic Characterization of Glioblastoma Intra-Tumor Heterogeneity Using OrbiSIMS

[Image: see text] Glioblastoma (GBM) is an incurable brain cancer with a median survival of less than two years from diagnosis. The standard treatment of GBM is multimodality therapy comprising surgical resection, radiation, and chemotherapy. However, prognosis remains poor, and there is an urgent n...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wenshi, Edney, Max K., Paine, Simon M. L., Griffiths, Rian L., Scurr, David J., Rahman, Ruman, Kim, Dong-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100400/
https://www.ncbi.nlm.nih.gov/pubmed/36995369
http://dx.doi.org/10.1021/acs.analchem.2c05807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100400/
https://www.ncbi.nlm.nih.gov/pubmed/36995369
http://dx.doi.org/10.1021/acs.analchem.2c05807

Ejemplares similares